adenosine A3 agonists (CV Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameadenosine A3 agonists (CV Therapeutics)
Drug Alias NameCVT-3641CVT-3866
ClassificationSmall molecules
Mechanisms of ActionAdenosine A3 receptor agonists
TargetsAdenosine A3 receptor
Therapy Area/IndicationsCardiovascular DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Palo Alto Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Palo Alto Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A